Azabicyclo [3.1.0] hexyl derivatives as modulators of dopamine D3 receptors
US8222266B2 · kind B2 · utility
0Cited by
2References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 30, 2007 |
| Grant date | Jul 17, 2012 |
| Priority date | — |
| Expiry date | Oct 24, 2028 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D405/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to certain azabicyclo compounds of formula (I)′:wherein the various groups are defined herein and that are modulators of dopamine D3 receptors, e.g. to treat drug dependency, as antipsychotic agents, to treat obsessive compulsive spectrum disorders, or premature ejaculation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.